CryoStor References
Abstracts
2024 | CryoStor® References | Abstracts
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol
Authors: A., Quiñones-Hinojosa, W.J., Sherman, J.J., Green, K.L., Chaichana, J.P., Almeida, S.Y., Tzeng, D.N., Abarbanel, E.H., Middlebrooks, D.W., Dickson, N., Durand, D.M., Trifiletti, A.C., Zubair, E.C., Szymkiewicz, A.N., Basil, E.L., Twohy, R., Al-Kharboosh, A., Ramos-Fresnedo
Published: Neurosurgery Practice, 2023;Dec;4:e00062
2023 | CryoStor® References | Abstracts
Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon Platform
Authors: A., Bryan, D., Leonard, T., Smith, K., Middleton, K., Purpura, N., Trainor
Published: Cytotherapy, 2023; 25:1349 - 1360
2022 | CryoStor® References | Abstracts
A Novel Cryopreservation and Biobanking Strategy to Study Lymphoid Tissue Stromal Cells in Lymphoproliferative Disorders
Authors: I., and Maillard, B., Ludewig, J.C., Aster, D.C., Fajgenbaum, D., Allman, G., Wertheim, E., Camiolo, Y., Stanossek, M., Gonzalez, B.T., Gaudette, A., Ferreira, M., Lϋetge, A., De Martin, J.D., Brandstadter
2019 | CryoStor® References | Abstracts
ESGCT 27th Annual Congress In collaboration with SETGyc Barcelona, Spain October 22–25, 2019 Abstracts: Manufacture of an ATMP for ex vivo gene therapy of mucopolysaccharidosis IIIA (MPSIIIA)
Authors: AJ, Thrasher, C., Booth, BW, Bigger, SA, Jones, R., Wynn, W., Ogden, C, Rivat, I., Pereira, D., León-Rico, A., Diasakou, E., Armenteros-Monterroso, SM, Ellison, KF, Buckland
Published: Human Gene Therapy.Nov 2019.A1-A221
2019 | CryoStor® References | Abstracts
Manufacture of an ATMP for ex vivo gene therapy of mucopolysaccharidosis IIIA (MPSIIIA)
Authors: AJ, Thrasher, C., Booth, BW, Bigger, SA, Jones, R., Wynn, W., Ogden, C., Rivat, I., Pereira, D., León-Rico, A., Diasakou, E., Armenteros-Monterroso, SM, Ellison, KF, Buckland
Published: Human Gene Therapy, 2019;30:11, A1-A221
2018 | CryoStor® References | Abstracts
A COMPARISON STUDY OF CURRENT FREEZING MEDIA VERSUS CRYOSTOR10 FOR CRYOPRESERVATION OF QC VIALS
Authors: B., Paciulan, K., Stasko, E., Clark
Published: Cytotherapy
2018 | CryoStor® References | Abstracts
A Comprehensive Review of Umbilical Cord Cryopreservation: Umbilical Cord Tissue Banking Cryopreserved Technology and Standard Operating Procedure
Authors: Tsung (John) Dao, Lee
Published: Transfusion
2017 | CryoStor® References | Abstracts
Banking of Human Pluripotent Stem Cells
Authors: Ntai A, Biunno I
Published: Biopreservation and Biobanking
2017 | CryoStor® References | Abstracts
Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units.
Authors: Pineault N., Elmoazzen H., Pasha R.
Published: Transfusion
2016 | CryoStor® References | Abstracts
Biopreservation considerations in the evolving field of cellular therapies
Authors: Abazari A
Published: Cryobiology
2016 | CryoStor® References | Abstracts
Influencing Differentiation and Growth of Neural Progenitor Cells With Gene Silencing and Laminin
Authors: Yian Chew S, Hon Chooi W, Ong W, Wyatt M
Published: Univeristy of Pittsburgh, Swanson School of Engineering, Undergraduate Summer Research Abstracts
2016 | CryoStor® References | Abstracts
Transplantation of cryopreserved MSC rescues retinal ganglion cells following I/R injury
Authors: et al., Ankrum JA, Burand A, Zhu W, Gramlich OW
Published: ARVO Journal
2014 | CryoStor® References | Abstracts
C-25: Evaluation of closed system medical device for low volume storage for clinical studies involving regulatory T cells.
Authors: Lombardi G., Bushell A, Lowe K, Thirkell S, Fazekasova H, Fearnot ER
Published: Cryobiology
2013 | CryoStor® References | Abstracts
Analysis of HPC and HSC post-thaw viability, clonogenic capacity, and proliferative potential after cryopreservation in comercially available media
Authors: Leemhuis T, Lutzko C, Almulhem N
Published: Cytotherapy
2013 | CryoStor® References | Abstracts
Phenotypic properties of transmitted founder HIV-1
Authors: et al., Zajic L, Parrish EH, Barbian HJ, Giorgi EE, Li H, Gao F, Parrish NF
Published: The Proceedings of the National Academy of Sciences (PNAS)
2012 | CryoStor® References | Abstracts
Cell-based approaches for the treatment of systemic inflammation.
Authors: Pino CJ, Yevzlin AS, Lee K, Westover AJ, Smith PL, Buffington DA, Humes HD.
Published: Nephrology Dialysis Transplantation
2009 | CryoStor® References | Abstracts
Notch-Induced Rat and Human Bone Marrow Stromal Cell Grafts Reduce Ischemic Cell Loss and Ameliorate Behavioral Deficits in Chronic Stroke Animals.
Authors: Borlongan CV., Case C, Bankiewicz K, McGrogan M, Xu L, Yu G, Bae E, Yu SJ, Ali MM, Maki M, Hara K, Matsukawa N, Yasuhara T
Published: Stem Cells and Development
September 2024 | CryoStor® References | Abstracts
Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collabo
Authors: S. for Biomedical Excellence for Safer Transfusion (BEST), Pati, H., Geng, D., Marks, M., Tanashi, D., Stroncek, J., Reems, P., Jin, D.H., McKenna, P.J., Norris, M.J., Fontaine, R., Schäfer, B.H., Shaz
Published: Cytotherapy, 2024;26; Issue 6:531-539
September 2024 | CryoStor® References | Abstracts
Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products
Authors: C.S., Cox Jr, S.D., Olson, J.C., Cardenas, B.S., Gill, F., Triolo, J.B., Schriner
Published: Cytotherapy: Stromal Cell Therapy, 2024;26, Issue 2:194 - 200